用户名: 密码: 验证码:
Ⅰ型胶原/聚乳酸/纳米羟基磷灰石共电纺构建三维组织工程支架
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
骨缺损是骨科常见并发症之一,如何有效的修补骨缺损,同时促进骨再生修复一直是骨科工作中的难题。在一些较大的骨缺损修复过程中,单纯依靠骨组织自身的再生和修复能力难以实现骨缺损的自然愈合,而且自身骨移植的骨块一般较小难以满足要求,因此骨移植材料特别是骨组织工程材料的应用在临床工作中将起到越来越大的作用。目前常用的组织工程材料的制作方法有:发泡法;纤维粘结法;自组装法;热凝胶法;颗粒沥滤法;静电纺丝法等。
     其中静电纺丝技术是一种利用高压电场控制聚合物在接收靶上进行沉积制作组织工程材料的一项前沿技术。通常静电纺丝法所用的溶剂都具有较高的挥发性,通过这项技术可以使聚合物溶液以非常高的速度在电场中螺旋运动,在此过程中溶剂迅速的挥发,剩余的聚合物被拉伸成很细的纤维,并最终以微米-纳米级纤维的形式收集在接收靶上。电纺可以使支架材料具有纳米级结构,制作纳米级三维仿生骨组织工程支架,改变支架的理化性质,促进成骨细胞的粘附、增殖和基因表达,从而达到促进骨再生修复的目的。以往静电纺丝法制备的纤维以单组份或双组分多见。本研究中,我们利用静电纺丝技术制作I型胶原/聚乳酸(poly(lactic acid);PLA)/纳米羟基磷灰石(nano-hydroxyapatite;nHA)三组分混纺支架材料,用于成骨细胞-支架共培养。其中I型胶原取自动物体内,其具有免疫原性低的特点。可以较好的避免免疫排斥;并可以被人体有效利用,形成骨组织。羟基磷灰石(HA)作为天然骨组织的成分之一,能够促进成骨细胞的粘附与钙化。PLA是骨组织工程学中常用的一种聚合物,具有可降解、毒性低的特点,可以在人体内降解、吸收,不会导致毒性反应。
     本研究的目的是探讨I型胶原、PLA单独电纺以及I型胶原/PLA/nHA混合电纺的条件及最佳参数,对其形态及表征进行分析,并观察I型胶原/PLA/nHA共电纺三维立体支架材料对成骨细胞48小时内黏附率及成骨细胞增殖率的影响。
     实验部分,我们分5章分别论述了(1)单纯I型胶原静电纺丝纤维的制备;(2)单纯PLA静电纺丝纤维的制备;(3)I型胶原/PLA/nHA静电纺丝支架的制备;(4)骨髓间充质干细胞分离、培养及成骨诱导;(5)细胞与支架共培养及生物学特性研究。通过研究发现:(1)单纯I型胶原和单纯PLA溶液可以通过静电纺丝技术制备纳米级纤维。采用静电纺丝技术构建I型胶原/PLA/nHA纳米纤维骨组织工程支架是可行的,同时混纺纤维在形态上明显优于单组分电纺纤维。(2)I型胶原/PLA/nHA纳米纤维成分组成和形态结构非常接近天然骨基质,在一定程度上达到了成分和结构仿生的目的。其中,I型胶原、PLA能够为细胞粘附提供必要的位点,高孔隙率的支架能够促进细胞的迁徙和增殖,HA通过为成骨细胞提供矿化原料达到调节成骨细胞矿化的作用。(3)通过体外实验发现,I型胶原/PLA/nHA纳米纤维能够促进成骨细胞粘附、增殖,因此其可能成为一种潜在的骨组织工程材料。
     本研究的创新性在于:(1)解决了I型胶原/聚乳酸/纳米羟基磷灰石共电纺时的相分离问题,成功构建三组份组织工程支架;(2)证实I型胶原/聚乳酸/纳米羟基磷灰石电纺纤维形态优于单组份电纺;(3)解决了以往电纺材料膜厚度增加速度较慢的问题,提高了电纺效率;(4)通过静电纺丝技术基本模拟了天然骨基质微观形态,在一定程度上达到了成分和形态仿生目的;(5)证实该新型材料对成骨细胞粘附、增殖具有促进作用。
In clinical work, big bone defects were nard to heal on their own ability of regeneration and restoration, and the bone for autographing was generally small or restricted by its shape, and was difficult to fulfill the requirement. Tissue Engineering provided a new method for born regeneration and restoration, thus more and more researchers focused on the field. At present, various medical materials has been widely utilized in clinic to repair many kinds of tissue defects and worked well to relieve patients’diseases. In the treatment of bone defects, Bone Tissue Engineering Scaffolds were thought to be one of the replacements for bone autographing. An excellent Tissue Engineering Scaffold should have the following features: high quality, reliability, durability and economy; besides it can be applied in the clinic as a medical material. As a bone tissue material, it should possess the feature of porousness, which helped to interact between cells and cells or cells and scaffolds. The 3D scaffolds can support the adhesion and proliferation of the cells, and can be applied as bone grafts. Now plentiful biomaterials have been prepared and come to use in the field of bone tissue engineering. According to their components, these materials can be classified into three as bioactive inorganic material, degradable polymer, and compound or hybrid structure containing the two above.
     Reviewing the recent studies, we know the component and morphology of the natural bone basically. The main components of the bone were collagen I, hydroxyapatite and water, and in the bone the mineral salts account for 65%, organic matters account for25%, and water 10%. Collagen I presented in the bone matrix, and the diameters of the collagen I fibers were several hundred nanometer. Hydroxyapatite formed the plate like structure and filled the gap among the collage I and the surface of it, and constituted the matrix. The plate like structures overlaid one another and formed the 3D porous structure. The components and morphology of the natural bone have prominent effect on the adhesion, proliferation and differentiation of Osteoblast. Recent years, there are many methods by which the components and morphology of the natural bone were imitated at home and abroad to prepare the bone tissue engineering materials. Beside them, Electrostatic Spinning was a technique utilizing the high voltage field to stretch and deposit on the target. The fibers electrospun had ultrastructure of micro-Nan scale, and can form big hole in materials.
     The purpose of this study is to prepare a Tissue Engineering Scaffold containing collagen-I/polylactic acid (PLA)/nanohydroxyapatite (nHA) using co-electrospinning methods; evaluate the feasibility of Co-electrospinning single and three components to prepare a novel Tissue Engineering Scaffold; imitate the components and morphostructure of natural bone in vitro; analyze the effect of collagen-I/ PLA/ nHA scaffold and PLA scaffold on Osteoblast and construct a tissue engineering bone. The novelty is that we solved the problem of dissolution of collagen-I/ PLA/ nHA for co-electrospinning, and prepared a tissue engineering scaffold containing three components successfully. We solved the issue that the membrane thickness of the electrospun material was hard to increase. By the technique of Electrostatic Spinning, we imitated the ultrastructure of natural bone basically, and this goal of preparing bionic materials was achieved to a certain extent through imitating the components and morphology. The new material was verified contributing to cell adhesion and proliferation.
     This study contains five parts.
     1. Preparation of Collagen I fibers by electrospinning
     This part of experiment was to explore the appropriate concentration of Collagen I solution and the feasibility of electrospinning it. The fittest parameters were analyzed. The morphology of Collagen I fibers were observed. Collagen I was dissolved in HFP in different concentration. Different conditions of dissolving Collagen I by persistent stirring, surfactant, heating were compared. The fittest concentration was analyzed. The homogeneous solution of Collagen I was electrospun. Through regulating voltage, electric field in unitdistance, the fit parameters of electrospinning were analyzed. By SEM, the morphology of Collagen I fibers were observed, and the diameters, density and porosity were measured. The surface features of the fibers were analyzed.
     2. Preparation of PLA fibers by electrospinning
     This part of experiment was to contrast the impacts of Chloroform solvent and HFP solvent on electrospinning PLA respectively; explore the optimum parameters for electrospinning PLA, and analyze the feasibility of Preparation of PLA fibers by electrospinning. The morphologic features of PLA fibers were observed. Different conditions of dissolving PLA in Chloroform and HFP. The concentrations of dissolving PLA for electrospinning were compared and the fit one was chosen at the end. The homogeneous solution of PLA was electrospun. Through regulating voltage, electric field in unitdistance, the fit parameters of electrospinning were analyzed. By SEM, the morphology of PLA fibers were observed, and the diameters, density and porosity were measured. The surface features of the fibers were analyzed.
     3. Preparation and surface features of Collagen I/PLA/nHA scaffolds by co- electrospinning
     The purpose of this part of the experiment was to eliminate the phase separation phenomenon of mix of Collagen I and PLA and prepare the homogenous Collagen I/PLA solution and to prepare the fibers of Collagen I/PLA/nHA by co-electrospinning. Through improving the target substrates, the thickness of the scaffold increased. The morphology and surface features of the fibers were observed. The PLA was dissolved in Chloroform and HFP respectively, and then blended with Collagen I HFP solution. The solutions were electrospun after being stirred 1h and 12h separately. The morphology of fibers and conditions of different solutions were observed and compared. As the reduction of targets area, the increased speed of scaffold’s thickness was observed in different diameters, and the optimal target area was selected. The parameters were optimized. By SEM, the morphology of Collagen I/PLA/nHA fibers were observed, and the diameters, density and porosity were measured. The surface features of the fibers were analyzed. The physicochemical properties of the Collagen I/PLA/nHA fibers were tested by FT-IR and XRD.
     4. Separation, culture and osteoinductive culture of the Bone Mesenchymal Stem Cells (BMSCs)
     The objective was to set up a scientific and efficient separating and culturing mode for BMSC. Through osteoinductive culture of the BMSC, the osteogenesis was tested, which provided cells for biological research of scaffolds in vitro. The BMSCs were isolated by density gradient centrifugation and were cultured. The results of morphology, growth cycle, and cell-stain were observed. The osteoinductive culturing cells were tested Alkaline Phosphatase (ALP) and produced calcified nodules.
     5. Co-culture of the Osteoblast and scaffolds and study of the biological features
     The objective was to discuss the effect of Collagen I/PLA/nHA 3-D scaffolds on the Osteoblast adherence and proliferation ratio in 48h. After 3h, 6h, 12h, 24h and 48h co-culturing, the cells were digested by trypsin, and the ones alive were accounted by Trypan blue staining. Then the adherence ratio was calculated. On the 1d, 3d, 5d, 7d, 9d, 12d of co-culture, the proliferation ratio of the Osteoblast was tested by means of MTT assay.
     This research gained following results
     1. Either continuous stirred 15 mg·ml-1, 20 mg·ml-1 Collagen I or with surfactants could be electrospun and got formed fibers, and gathered on the target substrate. The fibers’diameter of 20 mg·ml-1 Collagen I was 195 nm to 643 nm. The feed liquid was 1 ml·h-1, and the electric field was 2 kV·cm-1. Some connections of few fibers fused. The shape of them was irregular. Plentiful flat or oblate fibers could be seen, but the 3-D pattern was hard to find. The single Collagen I fibers were fragile.
     2. 40 mg·ml-1 PLA solution could be electrospun and got the best morphology and the largest poriness. The best feed liquid was 1 ml·h-1, and the electric field was 2 kV·cm-1. Compared with the Collagen I fibers, the PLA ones had a better 3-D structure. The fibers were mainly cylinder-shaped, and had more fusions. The fragility decreased obviously.
     3. PLA and Collagen I were mixed in proportion to 2:1. After being stirred 12 h, they became into homogeneous solution and the fibers electrospun could gathered on the target substrate. Electrospinning after adding 20% nHA, we found that 100nm to 150nm nHA roughness was present on the surface of the fibers due to the deposition of crystals of nHA along the long axis of the fibers. The average diameters of the fibers were 238 nm. The morphology of them improved than single Collagen I or PLA. The poriness could achieve above 90%. The chemical bonds of PLA, Collagen I and nHA could be tested by FT-IR, and it turned out to be that the chain structure of Collagen I did not be destroyed during the dissolving process. The peak of wave of nHA existed obviously when observed by XRD.
     4. The culture cells were isolated by density gradient centrifugation. They had the common features as human BMSCs in cell morphology, growth cycle and cell staining. After the osteoinductive culture 2w, the ALP positive staining could be observed, and by alizarin red the calcium nodes were apparent.
     5. The nano 3D collagen-I/PLA/nHA scaffolds fabricated by electrospinning could improve the adherence of osteoblast and raised the proliferation ratio.
     Conclusions Collagen-I and PLA both could be electrospun into nano-fibers separately. Fabrication of collagen-I/PLA/nHA nano-fibers for bone tissue engineering was feasible. Morphology of collagen-I/PLA/nHA fibers is better than that of collagen-I and PLA fibers. Composition and morphology of collagen-I/PLA/nHA fibers are similar to that of native bone tissue, so we have achieved the biomimetic purpose in some degree. In vitro test, scaffolds of collagen-I/PLA/nHA showed the ability to induce osteoblast adhesion and proliferation, so scaffolds of collagen-I/PLA/nHA are identified as potential bone tissue engineering scaffolds.
引文
[1] Goldberg M, Langer R, Jia X. Nanostructured materials for aplications in drug delivery and tissue engineering [J]. J Biomater Sci Polym Ed; 2007; 18(3):241-268.
    [2] Service RF. Tissue engineering. Coming soon to a knee near you: cartilage like your very own [J]. Science; 2008; 322(5907):1460-1461.
    [3] L'Heureux N, Germain L, Auger FA. Tissue engineering [J]. Science; 1999; 284(5420):1621-1622.
    [4] Perry CR. Bone repair techniques, bone graft, and bone graft substitutes [J]. Clin Orthop Relat Res; 1999(360):71-86.
    [5] Christenson EM, Anseth KS, van den Beucken JJ, et al. Nanobiomaterial applications in orthopedics [J]. J Orthop Res; 2007; 25(1):11-22.
    [6] Breuls RG, Jiya TU, Smit TH. Scaffold stiffness influences cell behavior: opportunities for skeletal tissue engineering [J]. Open Orthop J; 2008; 2:103-109.
    [7] Stevenson S. Enhancement of fracture healing with autogenous and allogeneic bone grafts [J]. Clin Orthop Relat Res; 1998(355 Suppl):S239-S246.
    [8] Aghaloo TL, Moy PK. Which hard tissue augmentation techniques are the most successful in furnishing bony support for implant placement? [J]. Int J Oral Maxillofac Implants; 2007; 22 Suppl:S49-S70.
    [9] Stevens MR, Emam HA, Alaily ME, et al. Implant bone rings. One-stage three-dimensional bone transplant technique: a case report [J]. J Oral Implantol; 2010; 36(1):69-74.
    [10] DeLustro F, Condell RA, Nguyen MA, et al. A comparative study of the biologic and immunologic response to medical devices derived from dermal collagen [J]. J Biomed Mater Res; 1986; 20(1):109-120.
    [11] Papadopulos NA, Weigand C, Kovacs L, et al. The free vascularized fibular epiphyseal transfer: long-term results of wrist reconstruction in young patients [J]. J Reconstr Microsurg; 2009;25(1):3-13.
    [12] Mozaffarian K, Lascombes P, Dautel G. Vascular basis of free transfer of proximal epiphysis and diaphysis of fibula: an anatomical study [J]. Arch Orthop Trauma Surg; 2009;129(2):183-187.
    [13] Arora R, Lutz M, Zimmermann R, et al. Free vascularised iliac bone graft for recalcitrant avascular nonunion of the scaphoid J]. J Bone Joint Surg Br; 2010;92(2):224-229.
    [14] Stevenson S, Emery SE, Goldberg VM. Factors affecting bone graft incorporation [J]. Clin Orthop Relat Res; 1996(324):66-74.
    [15] Burchardt H, Jones H, Glowczewskie F, et al. Freeze-dried allogeneic segmental cortical-bone grafts in dogs [J]. J Bone Joint Surg Am; 1978; 60(8):1082-1090.
    [16] Sefton MV, Woodhouse KA. Tissue engineering [J]. J Cutan Med Surg; 1998;3 Suppl 1:S18-S23.
    [17] Zhang J, Huang C, Xu Q, et al. Biological properties of a biomimetic membrane for guided tissue regeneration: a study in rat calvarial defects [J/OL]. Clin Oral Implants Res; 2010 [2010-1-22]. http://www3.interscience.wiley.com/journal/123250194/ bstract? CRETRY =1&SRETRY=0
    [18] Civin CI, Strauss LC, Brovall C, et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells [J]. J Immunol; 1984;133(1):157-165.
    [19] Haynesworth SE, Goshima J, Goldberg VM, et al. Characterization of cells with osteogenic potential from human marrow[J]. Bone; 1992;13(1):81-88.
    [20] Baddoo M, Hill K, Wilkinson R, et al. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection [J]. J Cell Biochem; 2003;89(6):1235-1249.
    [21] Garreta E, Genove E, Borros S, et al. Osteogenic differentiation of mouse embryonic stem cells and mouse embryonic fibroblasts in a three-dimensional self-assembling peptide scaffold[J]. Tissue Eng; 2006;12(8):2215-2227.
    [22] Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al. Mesenchymal precursor cells in the blood of normal individuals [J]. Arthritis Res; 2000;2(6):477-488.
    [23] Eghbali-Fatourechi GZ, Lamsam J, Fraser D, et al. Circulating osteoblast- lineage cells in humans [J]. N Engl J Med; 2005;352(19):1959-1966.
    [24] Yu HS, Jang JH, Kim TI, et al. Apatite-mineralized polycaprolactone nanofibrous web as a bone tissue regeneration substrate[J]. J Biomed Mater Res A; 2009; 88(3):747-754.
    [25] McCullen SD, Zhu Y, Bernacki SH, et al. Electrospun composite poly (L-lactic acid)/tricalcium phosphate scaffolds induce proliferation and osteogenic differentiation of human adipose-derived stem cells [J]. Biomed Mater; 2009; 4(3):350-352.
    [26] Bergsma JE, Rozema FR, Bos RR, et al. In vivo degradation and biocompatibility study of in vitro pre-degraded as-polymerized polyactide particles [J]. Biomaterials; 1995; 16(4):267-274.
    [27] Coutu DL, Yousefi AM, Galipeau J. Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapy [J]. J Cell Biochem; 2009; 108(3):537-546.
    [28] LeGeros RZ. Properties of osteoconductive biomaterials: calcium phosphates [J]. Clin Orthop Relat Res; 2002(395):81-98.
    [29] Matthews JA, Wnek GE, Simpson DG, et al. Electrospinning of collagen nanofibers[J]. Biomacromolecules; 2002;3(2):232-238.
    [30] Gigante A, Manzotti S, Bevilacqua C, et al. Adult mesenchymal stem cells forbone and cartilage engineering: effect of scaffold materials [J]. Eur J Histochem; 2008; 52(3):169-174.
    [31] Cho WJ, Kim JH, Oh SH, et al. Hydrophilized polycaprolactone nanofiber mesh-embedded poly (glycolic-co-lactic acid) membrane for effective guided bone regeneration [J]. J Biomed Mater Res A; 2009; 91(2):400-407.
    [32] Rives CB, des Rieux A, Zelivyanskaya M, et al. Layered PLG scaffolds for in vivo plasmid delivery [J]. Biomaterials; 2009; 30(3):394-401.
    [33] Zhang S, Gelain F, Zhao X. Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures [J]. Semin Cancer Biol; 2005;15(5):413-420.
    [34] Gelain F, Bottai D, Vescovi A, et al. Designer self-assembling Peptide nanofiber scaffolds for adult mouse neural stem cell 3-dimensional cultures[J]. PLoS ONE; 2006; 1:119.
    [35] Borden M, Attawia M, Khan Y, et al. Tissue engineered microsphere-based matrices for bone repair: design and evaluation [J]. Biomaterials; 2002; 23(2):551-559.
    [36] Song JH, Kim HE, Kim HW. Electrospun fibrous web of collagen-apatite precipitated nanocomposite for bone regeneration [J]. J Mater Sci Mater Med; 2008; 19(8):2925-2932.
    [37] Zeugolis DI, Khew ST, Yew ES, et al. Electro-spinning of pure collagen nano-fibres - just an expensive way to make gelatin? [J]. Biomaterials; 2008; 29(15):2293- 2305.
    [38] Baker BM, Mauck RL. The effect of nanofiber alignment on the maturation of engineered meniscus constructs [J]. Biomaterials; 2007; 28(11):1967-1977.
    [39] Christopherson GT, Song H, Mao HQ. The influence of fiber diameter of electrospun substrates on neural stem cell differentiation and proliferation [J]. Biomaterials; 2009; 30(4):556-564.
    [40] Hassenkam T, Fantner GE, Cutroni JA, et al. High-resolution AFM imaging ofintact and fractured trabecular bone [J]. Bone; 2004; 35(1):4-10.
    [41] M.C.DURRIEU, S.PALLU, F.GUILLEMOT, et al. Grafting RGD containing peptides onto hydroxyapatite to promote osteoblastic cells adhesion [J]. J Mater Sci Mater Med; 2004; 15:779-786.
    [42] Chen M, Michaud H, Bhowmick S. Controlled vacuum seeding as a means of generating uniform cellular distribution in electrospun polycaprolactone (PCL) scaffolds[J]. J Biomech Eng; 2009; 131(7):74-81.
    [43] Powell HM, Boyce ST. Engineered Human Skin Fabricated Using Electrospun Collagen-PCL Blends: Morphogenesis and Mechanical Properties [J]. Tissue Eng Part A; 2009; 15:1-11.
    [44] Badami AS, Kreke MR, Thompson MS, et al. Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly(lactic acid) substrates[J]. Biomaterials; 2006; 27(4):596-606.
    [45] Kim HW, Yu HS, Lee HH. Nanofibrous matrices of poly (lactic acid) and gelatin polymeric blends for the improvement of cellular responses [J]. J Biomed Mater Res A; 2008; 87(1):25-32.
    [46] Ma Z, He W, Yong T, et al. Grafting of gelatin on electrospun poly (caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell Orientation [J]. Tissue Eng; 2005; 11(7-8):1149-1158.
    [47] Shabani I, Haddadi-Asl V, Seyedjafari E, et al. Improved infiltration of stem cells on electrospun nanofibers [J]. Biochem Biophys Res Commun; 2009; 382(1):129-133.
    [48] Sasaki N, Sudoh Y. X-ray pole figure analysis of apatite crystals and collagen molecules in bone [J]. Calcif Tissue Int; 1997; 60(4):361-367.
    [49] Taton TA. Nanotechnology. Boning up on biology [J]. Nature; 2001; 412(6846):491-492.
    [50] Li C, Vepari C, Jin HJ, et al. Electrospun silk-BMP-2 scaffolds for bone tissue engineering[J]. Biomaterials; 2006; 27(16):3115-3124.
    [51] Jiang H, Hu Y, Zhao P, et al. Modulation of protein release from biodegradable core-shell structured fibers prepared by coaxial electrospinning [J]. J Biomed Mater Res B Appl Biomater; 2006; 79(1):50-57.
    [52] Kikuchi M, Itoh S, Ichinose S, et al. Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthesized in vitro and its biological reaction in vivo [J]. Biomaterials; 2001;22(13):1705-1711.
    [53] Kim HW, Lee HH, Knowles JC. Nanofibrous glass tailored with apatite-fibronectin interface for bone cell stimulation [J]. J Nanosci Nanotechnol; 2008; 8(6):3013-3019.
    [54] Kim HW, Song JH, Kim HE. Bioactive glass nanofiber-collagen nanocomposite as a novel bone regeneration matrix [J]. J Biomed Mater Res A; 2006; 79(3):698-705.
    [55] Olszta MJ. Bone structure and formation: A new perspective [J]. Materials Science & Engineering. R, Reports; 2007; 58:77-116.
    [56] Rezwan K, Chen QZ, Blaker JJ, et al. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering [J]. Biomaterials; 2006; 27(18):3413-3431.
    [57] Wei G, Ma PX. Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering [J]. Biomaterials; 2004; 25(19):4749-4757.
    [58] Yang X, Shah JD, Wang H. Nanofiber Enabled Layer-by-Layer Approach Toward Three-Dimensional Tissue Formation [J]. Tissue Eng Part A; 2009; 15(4):945-956.
    [59] Kim HW, Lee HH, Knowles JC. Electrospinning biomedical nanocomposite fibers of hydroxyapatite/poly (lactic acid) for bone regeneration [J]. J Biomed Mater Res A; 2006; 79(3):643-649.
    [60] Song JH, Yoon BH, Kim HE, et al. Bioactive and degradable hybridized nanofibers of gelatin-siloxane for bone regeneration [J]. J Biomed Mater Res A; 2008; 84(4):875-884.
    [61] Erisken C, Kalyon DM, Wang H. Functionally graded electrospun polycaprolactone and beta-tricalcium phosphate nanocomposites for tissue engineering applications[J]. Biomaterials; 2008; 29(30):4065-4073.
    [62] Ashammakhi N, Wimpenny I, Nikkola L, et al. Electrospinning: methods and development of biodegradable nanofibres for drug release [J]. J Biomed Nanotechnol; 2009; 5(1):1-19.
    [63] Gao D, Xu H, Philbert MA, et al. Bioeliminable Nanohydrogels for Drug Delivery[J]. Nano Lett; 2008; 8(10):3320-3324.
    [64] Lee JJ, Yu HS, Hong SJ, et al. Nanofibrous membrane of collagen-polycaprolactone for cell growth and tissue regeneration [J]. J Mater Sci Mater Med; 2009; 20(9):1927-1935.
    [65] Venugopal J, Low S, Choon AT, et al. Mineralization of osteoblasts with electrospun collagen/hydroxyapatite nanofibers [J]. J Mater Sci Mater Med; 2008; 19(5):2039-2046.
    [66] Mattanavee W, Suwantong O, Puthong S, et al. Immobilization of biomolecules on the surface of electrospun polycaprolactone fibrous scaffolds for tissue engineering [J]. ACS Appl Mater Interfaces; 2009;1(5):1076-1085.
    [67] Zhu Y, Liu T, Song K, et al. Collagen-chitosan polymer as a scaffold for the proliferation of human adipose tissue-derived stem cells [J]. J Mater Sci Mater Med; 2009; 20(3):799-808.
    [68] Ngiam M, Liao S, Patil AJ, et al. Fabrication of mineralized polymeric nanofibrous composites for bone graft materials [J]. Tissue Eng Part A; 2009; 15(3):535-546.
    [69] Wang D, Miller SC, Kopeckova P, et al. Bone-targeting macromolecular therapeutics[J]. Adv Drug Deliv Rev; 2005; 57(7):1049-1076.
    [70] Benesch J, Mano JF, Reis RL. Proteins and their peptide motifs in acellular apatite mineralization of scaffolds for tissue engineering [J]. Tissue Eng Part B Rev; 2008; 14(4):433-445.
    [71] Alvarez-Barreto JF, Shreve MC, Deangelis PL, et al. Preparation of a functionally flexible, three-dimensional, biomimetic poly (L-lactic acid) scaffold with improved cell adhesion[J]. Tissue Eng; 2007; 13(6):1205-1217.
    [72] Kim TG, Park TG. Biomimicking extracellular matrix: cell adhesive RGD peptide modified electrospun poly(D,L-lactic-co-glycolic acid) nanofiber mesh[J]. Tissue Eng; 2006; 12(2):221-233.
    [73] Massia SP, Hubbell JA. An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation[J]. J Cell Biol; 1991; 114(5):1089-1100.
    [74] Secchi AG, Grigoriou V, Shapiro IM, et al. RGDS peptides immobilized on titanium alloy stimulate bone cell attachment, differentiation and confer resistance to apoptosis[J]. J Biomed Mater Res A; 2007; 83(3):577-584.
    [75] Fathi-Azarbayjani A, Chan SY. Single and multi-layered nanofibers for rapid and controlled drug delivery[J]. Chem Pharm Bull (Tokyo); 2010; 58(2):143-146.
    [76] Luu YK, Kim K, Hsiao BS, et al. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers [J]. J Control Release; 2003; 89(2):341-353.
    [77] Heiss G, Lapiene V, Kukolka F, et al. Single-Molecule Investigations of a Photoswitchable Nanodevice [J]. Small; 2009; 5(10):1069-1075.
    [78] Kim K, Luu YK, Chang C, et al. Incorporation and controlled release of ahydrophilic antibiotic using poly (lactide-co-glycolide)-based electrospun nanofibrous scaffolds[J]. J Control Release; 2004; 98(1):47-56.
    [79] Hadjiargyrou M, Chiu JB. Enhanced composite electrospun nanofiber scaffolds for use in drug delivery[J]. Expert Opin Drug Deliv; 2008; 5(10):1093-1106.
    [80] Srikar R, Yarin AL, Megaridis CM, et al. Desorption-limited mechanism of release from polymer nanofibers [J]. Langmuir; 2008; 24(3):965-974.
    [81] Rouwkema J, Rivron NC, van Blitterswijk CA. Vascularization in tissue engineering[J]. Trends Biotechnol; 2008; 26(8):434-441.
    [82] Lee YH, Lee JH, An IG, et al. Electrospun dual-porosity structure and biodegradation morphology of Montmorillonite reinforced PLLA nanocomposite scaffolds[J]. Biomaterials; 2005; 26(16):3165-3172.
    [83] Tuzlakoglu K, Bolgen N, Salgado AJ, et al. Nano- and micro-fiber combined scaffolds: a new architecture for bone tissue engineering [J]. J Mater Sci Mater Med; 2005; 16(12):1099-1104.
    [84] Park SH, Kim TG, Kim HC, et al. Development of dual scale scaffolds via direct polymer melt deposition and electrospinning for applications in tissue regeneration [J]. Acta Biomater; 2008; 4(5):1198-1207.
    [85]赵瑾,赵玉平,张伟,等. PLGA/明胶共混体系的静电纺丝研究[J].高等学校化学学报; 2009; 2:391-395.
    [86]黄绘敏,李振宇,杨帆,等.静电纺丝法制备超细聚苯乙烯纳米纤维[J].高等学校化学学报; 2007; 6:1200-1202.
    [87] Newton D, Mahajan R, Ayres C, et al. Regulation of material properties in electrospun scaffolds: Role of cross-linking and fiber tertiary structure [J]. Acta Biomater; 2009; 5(1):518-529.
    [88] Perumal S, Antipova O, Orgel JP. Collagen fibril architecture, domainorganization, and triple-helical conformation govern its proteolysis [J]. Proc Natl Acad Sci U S A; 2008; 105(8):2824-2829.
    [89] Thomas V, Dean DR, Jose MV, et al. Nanostructured biocomposite scaffolds based on collagen coelectrospun with nanohydroxyapatite [J]. Biomacromolecules; 2007; 8(2):631-637.
    [90]李常胜,李从举,付中玉,等.静电纺PLA微/纳米纤维膜的浸润性能研究[J].合成纤维工业; 2007; 4:17-19.
    [91]贾骏,段嫄嫄,陈亚芍,等.胶原改性PLGA电纺纤维的制备及其细胞相容性研究[J].临床口腔医学杂志; 2007; 6:5-7.
    [92] Kenawy el R, Bowlin GL, Mansfield K, et al. Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinylacetate), poly(lactic acid), and a blend[J]. J Control Release; 2002; 81(1-2):57-64.
    [93]徐峰,齐欣,王明礼,等.聚乳酸电纺构建仿生骨基质结构生物降解材料的体外细胞毒理研究[J].中国老年学杂志; 2009;1:68-69.
    [94]王琳,邓旭亮,梅芳,等.电纺左旋聚乳酸和左旋聚乳酸羟基磷灰石纳米纤维细胞相容性的比较研究[J].口腔颌面修复学杂志; 2007;2:9-12.
    [95] Ma PX. Biomimetic materials for tissue engineering [J]. Adv Drug Deliv Rev; 2008; 60(2):184-198.
    [96] de Mattos Carvalho A, Alves AL, Golim MA, et al. Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue[J]. Vet Immunol Immunopathol; 2009;132(2-4):303-306.
    [97] Hegab AE, Kubo H, Fujino N, et al. Isolation and Characterization of Murine Multipotent Lung Stem Cells[J/OL]. Stem Cells Dev; 2010 [2010-3-22]. http://www. liebertonline. com/doi/abs/10.1089/scd.2009.0287
    [98] Rui YF, Lui PP, Li G, et al. Isolation and Characterization of Multipotent RatTendon-Derived Stem Cells [J/OL]. Tissue Eng Part A; 2010 [2010-2-8]. http://www.liebertonline.com/doi/abs/10.1089/ten.TEA.2009.0529?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov
    [99] Tropel P, Noel D, Platet N, et al. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow[J]. Exp Cell Res; 2004; 295(2):395-406.
    [100] Gnecchi M, Melo LG. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium[J]. Methods Mol Biol; 2009; 482:281-294.
    [101] Tian X, Fu R, Deng L. Method and conditions of isolation and proliferation of multipotent mesenchymal stem cells [J]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007; 21(1):81-85.
    [102]徐丽丽,杨乃龙.体外诱导人骨髓间充质干细胞向成骨细胞的分化[J].中国组织工程研究与临床康复; 2008; 38:7483-7486.
    [103] Nuttall ME, Patton AJ, Olivera DL, et al. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders [J]. J Bone Miner Res; 1998; 13(3):371-382.
    [104] Ghilzon R, McCulloch CA, Zohar R. Stromal mesenchymal progenitor cells [J]. Leuk Lymphoma; 1999; 32(3-4):211-221.
    [105] Zohar R, Sodek J, McCulloch CA. Characterization of stromal progenitor cells enriched by flow cytometry[J]. Blood; 1997; 90(9):3471-3481.
    [106] Zhang Y, Reddy VJ, Wong SY, et al. Enhanced Biomineralization in Osteoblasts on a Novel Electrospun Biocomposite Nanofibrous Substrate of Hydroxyapatite /Collagen/Chitosan [J/OL]. Tissue Eng Part A; 2010 [2010-3-1]. http://www. liebertonline. com/doi/abs/10.1089/ten.TEA.2009.0221?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov
    [107] Sahoo S, Ang LT, Goh JC, et al. Growth factor delivery through electrospun nanofibers in scaffolds for tissue engineering applications [J/OL]. J Biomed Mater Res A; 2009 [2009-12-14]. http://www3.interscience.wiley.com/journal/ 123213598/abstract
    [108] Sahoo S, Ang LT, Cho-Hong Goh J, et al. Bioactive nanofibers for fibroblastic differentiation of mesenchymal precursor cells for ligament/tendon tissue engineering applications[J]. Differentiation; 2010; 79(2):102-110.
    [109] Wang S, Zhang Y, Wang H, et al. Fabrication and properties of the electrospun polylactide/silk fibroin-gelatin composite tubular scaffold [J]. Biomacromolecules; 2009; 10(8):2240-2244.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700